Logo redesign

Aeonian Pharmaceuticals, a San Francisco Bay Area-based biopharmaceutical company is an early-stage company engaged in the discovery and development of compounds harnessing the latest scientific breakthroughs to treat multiple diseases by addressing the underlying causes of disease initiation and progression, such as oxidative, cellular, and environmental stress. The Company’s lead compounds are novel and highly selective therapeutics modulating the mTORC1 pathway in order to treat rare diseases. We are honored that we were selected to create their logo.